Wikisage, the free encyclopedia of the second generation, is digital heritage
Hyperhomocysteinemia: Difference between revisions
Jump to navigation
Jump to search
(2nd) |
(ref) |
||
| Line 6: | Line 6: | ||
*Arroyo Jossue et al 2015 | *Arroyo Jossue et al 2015 | ||
[http://www.scielo.cl/pdf/rmc/v143n5/art02.pdf La metilación global del ADN y los niveles de homocisteína en plasma se encuentran disminuidos en pacientes con diabetes mellitus tipo 1 (Global DNA methylation and homocysteine levels are lower in type 1 diabetes patients)] rev Med Chile: 143: 562-568 | [http://www.scielo.cl/pdf/rmc/v143n5/art02.pdf La metilación global del ADN y los niveles de homocisteína en plasma se encuentran disminuidos en pacientes con diabetes mellitus tipo 1 (Global DNA methylation and homocysteine levels are lower in type 1 diabetes patients)] rev Med Chile: 143: 562-568 | ||
*Peirong Huang et al 2015 | |||
[http://www.nature.com/srep/2015/150721/srep10585/pdf/srep10585.pdf Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis] Sci Rep | |||
[[nl:Hyperhomocysteïnemie]] | [[nl:Hyperhomocysteïnemie]] | ||
Revision as of 23:22, 28 July 2015
Hyperhomocysteinemia or hyperhomocysteinaemia is a medical condition characterized by an abnormally high level of homocysteine in the blood, conventionally described as above 15 µmol/L
Disease classification WHO
hyperhomocisteinaemia E 72.1
Numata et al.2015
- Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis BMC Mol.Genetics ;16:54. doi: 10.1186/s12881-015-0197-7.
- Arroyo Jossue et al 2015
La metilación global del ADN y los niveles de homocisteína en plasma se encuentran disminuidos en pacientes con diabetes mellitus tipo 1 (Global DNA methylation and homocysteine levels are lower in type 1 diabetes patients) rev Med Chile: 143: 562-568
- Peirong Huang et al 2015
Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis Sci Rep